PTSM: Pharmaceutical Technology Sourcing and Management, Aug 4, 2011 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Aug 4, 2011
Sourcing
Strategies for Innovation in Pharmaceutical Sourcing and Procurement
By Patricia Van Arnum
Pharmaceutical companies and their suppliers share approaches for innovation in sourcing and procurement.
Outsourcing
Offsetting Budget Cuts
By Gregg Brandyberry
Better strategies and practices in sourcing and procurement can contribute to the bottom line.
Supply Chain
Industry Experts Focus on Ways to Best Manage the Global Pharmaceutical Supply Chain
By Patricia Van Arnum
Xavier University, in partnership with FDA, will hold a conference in October to focus on the changing regulatory, business, and operational issues affecting the global pharmaceutical supply chain.
CSR and Sustainability Forum
Advancing Green Chemistry in Pharmaceutical Applications
By Patricia Van Arnum
EPA's Presidential Green Chemistry Awards recognize developments in green chemistry, including those in pharmaceutical applications.
Building Pharmaceutical Scientific Capacity in the Developing World
By Patricia Van Arnum
GlaxoSmithKline is among the companies building scientific capacity to address diseases in the developing world.
Improving the Delivery of Maternal and Children's Healthcare Services
By Patricia Van Arnum
The US Agency for International Development, the government of Norway, the Bill and Melinda Gates Foundation, Grand Challenges Canada, and The World Bank partner to bring innovative solutions to improve maternal and children’s health in the developing world.
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here